Practice Updates in Genitourinary Molecular Oncology: A Case Based Approach

Course overview

In line with all areas of molecular oncology, molecular testing has also expanded into the area of genitourinary tumors, providing insight into pathobiology of these tumors as well as significantly aiding in identifying diagnostic, prognostic and predictive biomarkers. Most recent guidelines from professional societies now include recommendations for relevant molecular testing in genitourinary tumors to complement the clinical practice. In this presentation, a case-based format is used to exemplify relevant established and emerging standard of care molecular biomarkers in genitourinary tumors and how pathologists can use available data from molecular pathology reports to help in their practice. The presentation will also provide guidance in selecting appropriate testing methodologies for the required assays. Learning objectives: Outline the standard of care molecular testing practices in genitourinary tumors. Explain molecular alterations seen in genitourinary tumors. Discuss, using case scenarios, how pathologists can use molecular testing for the purpose of diagnosis, suggest hereditary predisposition and testing, and integrate information from molecular tests to pathology reports